Part 1/13:
The Complex Debate Over GLP-1 Drugs for Obesity: Insights, Controversies, and the Path Forward
The conversation surrounding GLP-1 receptor agonists—powerful drugs originally developed to manage type 2 diabetes—has become one of the most contentious topics in modern medicine and public discourse. This long-form article explores a detailed debate between medical experts, highlighting the promise, controversies, and nuances involved in using these medications for obesity treatment.